昏迷状态
发表于 2025-3-30 11:26:48
http://reply.papertrans.cn/47/4682/468178/468178_51.png
INTER
发表于 2025-3-30 12:38:51
http://reply.papertrans.cn/47/4682/468178/468178_52.png
描绘
发表于 2025-3-30 20:13:30
http://reply.papertrans.cn/47/4682/468178/468178_53.png
Inscrutable
发表于 2025-3-30 23:21:14
The Liver and Insulin Resistance: The Important Convergence of Endocrinology and Hepatologyibes the association between cirrhosis and development of diabetes (1) and more recently to the term “diabetic fatty liver” which antedated the now more common terms “nonalcoholic steatohepatitis” (NASH) and “nonalcoholic fatty liver disease” (NAFLD). These terms were introduced in the 1980s and 199
prolate
发表于 2025-3-31 02:03:34
Polycystic Ovary Syndrome and Metabolic Syndromeany clinical and biochemical features of metabolic syndrome, putting them at increased risk for diabetes and cardiovascular diseases. In the past 15 years, the key role of insulin resistance (IR) in the pathogenesis of PCOS has been stressed, and this common etiology between the two syndromes might
Infiltrate
发表于 2025-3-31 07:20:42
Effects of Exercise in Metabolic Syndrome and Diabetes: A Central Role for Insulin Sensitivityhysical inactivity predict mortality in both normal-weight and obese men, in older men and women, and in men with type 2 diabetes mellitus (T2DM) (1–9). Sedentary behavior has been clearly implicated as a factor leading to the development of diabetes, as well as the worsening of cardiovascular (CV)
防水
发表于 2025-3-31 09:25:55
Weight Loss Medications and the Metabolic Syndromeronary artery disease, as well as increased mortality rates (1–6). It is also clear that weight loss can markedly improve insulin resistance (IR) and other markers of adverse health risks in obese individuals (7–9). The challenge is how to help obese patients achieve and maintain weight loss. Curren
Insatiable
发表于 2025-3-31 17:10:05
The Metabolic Syndrome: Definitions, Controversies and Clinical Utilityn, and is associated with a high risk of developing type 2 diabetes mellitus (T2DM) in individuals without diabetes at presentation. The worldwide obesity and diabetes epidemics and the finding of a high prevalence of MetS in adults and adolescents (1, 2) have greatly increased interest in the definition and potential treatment of this syndrome.